Hypercalcemia related to cholangiocellular carcinoma

dc.contributor.authorOnalan, Erhan
dc.date.accessioned2026-08-12T17:18:03Z
dc.date.issued2019
dc.departmentFırat Üniversitesi
dc.description.abstractPatients with malignancies may develop hypercalcemia due to bone metastases or paraneoplastic reasons. Hepatocellular cancer should be considered in liver masses detected in chronic viral hepatitis B patients with delta agents. However, in our case, we detected cholangiocellular carcinoma in the etiology of hypercalcemia.
dc.identifier.doi10.1002/ccr3.2286
dc.identifier.endpage1544
dc.identifier.issn2050-0904
dc.identifier.issue8
dc.identifier.orcid0000-0001-5395-0390
dc.identifier.pmid31428385
dc.identifier.scopus2-s2.0-85068401650
dc.identifier.scopusqualityN/A
dc.identifier.startpage1542
dc.identifier.urihttps://doi.org/10.1002/ccr3.2286
dc.identifier.urihttps://hdl.handle.net/11508/52901
dc.identifier.volume7
dc.identifier.wosWOS:000474054800001
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherWiley
dc.relation.ispartofClinical Case Reports
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_WoS_20260511
dc.subjectcholangiocellular cancer
dc.subjectdelta hepatitis
dc.subjecthypercalcemia
dc.subjectmalignancie
dc.subjectparaneoplastic
dc.titleHypercalcemia related to cholangiocellular carcinoma
dc.typeArticle

Dosyalar